INTRODUCTION
Almost all cystic fibrosis (CF) centres give intravenous (i.v.) antibiotics either routinely or at the earliest sign ofrespiratory exacerbation. Enthusiasm for this more vigorous and aggressive approach, which possibly brings a better hope for survival1, has been, 'dampened by the enormous disruption to schooling, home life and thefamily brought about by spending 8 out of 52 weeks peryear in hospital'2. Much pressure for the same treatment to be given at home has come from parents and the patients themselves, who are eager to perform the task of drug administration which they perceive to be simple. Home treatment of CF with i.v. antibiotics is now widely established and its provision by CF centres is one ofthe recommendations made by the Clinical Standards Advisory Group3.
* The patient should usually be old enough to cooperate with an i.v. infusion. Parents cannot be expected to safely administer i.v. antibiotics and at the same time restrain an infant who is thrashing around. * The family must understand the need to contact the CF team when problems arise with the i.v. line, and must be prepared to make journeys to hospital for this. Families in whom in the past there has been a marked reluctance to seek medical help when it is needed are unsuitable. * The family must understand the need for testing blood levels of certain antibiotics (e.g. aminoglycosides) and must be prepared to make journeys to the hospital for this (unless the CF centre or local community services have the facility for a nurse to visit the home to obtain the relevant samples). * The family should have a clean work surface at home where antibiotics can be reconstituted ready for administration. Patients who are supplied with reconstituted antibiotics will need a refrigerator. * The family should have a telephone at home, so that they can easily and quickly access advice or rapidly arrange transport to hospital in the event of a complication, e.g. haemorrhage from the insertion site. * The family should have a car or easy access to one to facilitate transport to hospital. * of observing the procedure, to being able to safely and competently complete the whole process at home without prompting. Training in hospital usually extends over two 14 day courses for three reasons. The first is to ensure that the patient does not react adversely to the antibiotics in use. The second is to allow sufficient time to train the parents. It may take several courses of inpatient treatment before the patient and staff are confident that training is complete. Finally, a gap between courses is essential to check that skills have been retained.
Step by step guidelines are invaluable in the initial training period and act as an easy to follow guide to good practice. The most important section of the guidelines covers the preparation of the antibiotic and includes 16 pointers, from washing hands to expelling any remaining air bubbles from the antibiotic, prior to administration (see Table 1 ).
It is important that these guidelines are followed by the ward-based nursing team during the training of families, to ensure continuity. It is also recommended that a copy of the guidelines is retained by the families on completion of the initial training period. The guidelines used at Booth Hall Children's Hospital clinic are broken down into the following aspects: * Why your child needs intravenous antibiotics? * How often will your child need treatment? * How will you be trained? * Preparing the antibiotic (see Table 1 ). * Preparing the heparin and saline (see Table 2 ). * Disposal of equipment (see Table 3 ). * Preparing the giving set (see Table 4 ) * Administering antibiotics through the giving set (see Table 5 ) Table 6 ). Table 7 ). * Problems with long lines (see Table 8 ). * Totally implantable venous access devices (see Table 9 ). * Problems with totally implantable venous access devices (see Table 10 ). Standard practice involves keeping a record of the parents' progress. The benefits of such a record are that different members of the mutli-disciplinary team can see at a glance how training is progressing. These written records of competence are retained within the patient's medical notes.
Once home i.v. antibiotic therapy is under way, a record card is issued, to be completed during each 14 day course of i.v. antibiotics. This provides information about the size of the antibiotic ampoule, the volume of water to be added to each ampoule, the volume of solution to be drawn up, the volume of solution to be given and details the guidelines to be followed during the administration of the antibiotic. It also contains a daily record of cough, sputum production, peak expiratory flow and details of any problems or comments. This ensures that the patient's condition is monitored throughout the two week course, to aid decisions about future treatment.
Prior to the commencement of each course of i.v. antibiotics the patient's sputum cultures are checked to identify the most suitable antibiotic. A request is then sent to the general practitioner, who prescribes the i.v. antibiotic, any dilutants and the necessary flushing solutions (sodium chloride and heparinized saline). Either the hospital or the community services supply the syringes, needles, alcohol wipes, sharps bins and bandages. Patients attend the hospital for venous access to be established. The first dose of each course of i.v. antibiotics is always given in hospital to ensure the accuracy of the parents' technique and to ensure that the patient has not developed a hypersensitivity to the antibiotic.
At the start of each course of i.v. antibiotics the patient is weighed and the dose calculated, then instructions for reconstituting and administering the antibiotics are written on the card. It is essential that the parents of all patients on home i.v. antibiotic therapy have 24 h open access to the hospital. Our practice is to continue to collect sputum samples that are sent into the hospital by post during home i.v. treatment in order to detect the emergence of resistance to the antibiotics. Totally implantable venous access devices are mainly used by patients in whom ordinary peripheral venous access has become difficult or impossible. The device is made up of two components, a thin flexible catheter attached to a chamber with a self sealing injection port (Figures 1, 2) . The whole unit is implanted surgically under the skin, usually in a convenient but inconspicuous location on the chest or arm. There is no permanent opening on the skin surface.
For those who need them, implanted devices allow easy and long lasting venous access. There are however numerous associated disadvantages, a general anaesthetic may be required for the initial insertion of the port. Additionally, there is a risk of infection and the possibility that the device becomes blocked. Health professionals, whether they are doctors or nurses, require specialist training to flush, access or troubleshoot these ports. The device requires flushing every four weeks in order to maintain its patency.
DRUG INFUSION DEVICES
In order to make home intravenous antibiotic therapy easier a number of systems using premixed drugs have been developed. These devices comprise a closed system which is supplied ready filled with each individual dose of the patient's prescription. There are a number of such devices Figure 3) , the 'Intermate' (Baxter Homecare Ltd) and the 'Sidekick' (I-Flow, Figure 4 ). The reconstituted antibiotics are delivered preloaded in the infusion device to the patient's home where they are stored in a refrigerator until needed. The advantages of this type of system are a reduction in time to prepare the antibiotics for administration, making the system more convenient for both the patient and the carer. The main disadvantage of these systems is their enormous cost. Additionally, not all antibiotics are suitable for use in these devices because of instability of the antibiotic solution. totally implantable venous access device, it was observed that the mother was pulling the needle caps off the syringes of reconstituted antibiotics with her teeth. Discussions revealed that the child's mother was totally unaware of her actions, which had become subconscious.
Another example of poor technique was detected on a home visit when a family was making up 24 h worth of i.v. antibiotics at the same time, and storing the drug uncovered in a domestic refrigerator. This family was unaware that this was unsafe. They had noted that when in hospital 24 h worth of i.v. antibiotics were delivered at the same time and stored in a refrigerator. What they had failed to recognize was that the antibiotics were reconstituted in an aseptic suite, that they were delivered in sealed packets and that they were stored in a specially controlled refrigerator specifically designed for drug storage.
III. Reluctance to follow advice. A child receiving an aminoglycoside was found to have toxic serum levels, and the family were instructed to reduce the dose.
They dechned to do so, because they believed that a higher dosage was needed.
THE ROLE OF THE CYSTIC FIBROSIS NURSE SPECIALIST
One of the main tasks of the cystic fibrosis nurse specialist is to provide training and supervision of families who are to take on the responsibility of home i.v. antibiotic therapy.
Once parental training has been completed, there is a need for monitoring progress and compliance, as well as I-Flow) (Central Laboratories Ltd)
providing support to the patients and their families.
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Another task is to feed information back to the CF team at the hospital. Home visits by cystic fibrosis nurse specialists often permit a better assessment of problems than that which could be achieved in the outpatient department.
Monitoring and follow-up of families on home i.v. antibiotics may involve home visits, phone calls or clinic visits. There are no rules concerning the times of antibiotic doses but, as in hospital most families choose to give the antibiotic doses at 08:00h, 16:00h and 24:00h in order that disruptions to the school day are kept to a minimum.
CONCLUSION
Whilst recognizing the valuable contribution that the provision of a home i.v. antibiotic programme can make to the quality of patients lives, it should not be forgotten that for some, home treatment is not always practicable or indeed possible. The provision of a home i.v. antibiotic programme should not therefore be at the expense of inpatient services, nor should home care provision be based purely on its merits as a means of saving costs. In order to fulfil patient needs and maintain standards home care needs to be fully resourced.
